1
|
Nguyen HT, Tang W, Webster ALH, Whiteaker JR, Chandler CM, Errazquin R, Roohollahi K, Fritzke M, Hoskins EE, Jonlin E, Wakefield L, Sullivan LB, Chen EY, Dorsman J, Brakenhoff R, Paulovich AG, Grompe M, Garcia-Escudero R, Wells SI, Smogorzewska A, Monnat RJ. Fanconi anemia-isogenic head and neck cancer cell line pairs: A basic and translational science resource. Int J Cancer 2023; 153:183-196. [PMID: 36912284 DOI: 10.1002/ijc.34506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2022] [Revised: 01/27/2023] [Accepted: 02/15/2023] [Indexed: 03/14/2023]
Abstract
Fanconi anemia (FA) is a heritable malformation, bone marrow failure and cancer predisposition syndrome that confers an exceptionally high risk of squamous carcinomas. These carcinomas originate in epithelia lining the mouth, proximal esophagus, vulva and anus: their origins are not understood, and no effective ways have been identified to prevent or delay their appearance. Many FA-associated carcinomas are also therapeutically challenging: they may be multi-focal and stage-advanced at diagnosis, and most individuals with FA cannot tolerate standard-of-care systemic therapies such as DNA cross-linking drugs or ionizing radiation due to constitutional DNA damage hypersensitivity. We developed the Fanconi Anemia Cancer Cell Line Resource (FA-CCLR) to foster new work on the origins, treatment and prevention of FA-associated carcinomas. The FA-CCLR consists of Fanconi-isogenic head and neck squamous cell carcinoma (HNSCC) cell line pairs generated from five individuals with FA-associated HNSCC, and five individuals with sporadic HNSCC. Sporadic, isogenic HNSCC cell line pairs were generated in parallel with FA patient-derived isogenic cell line pairs to provide comparable experimental material to use to identify cell and molecular phenotypes driven by germline or somatic loss of Fanconi pathway function, and the subset of these FA-dependent phenotypes that can be modified, complemented or suppressed. All 10 FANC-isogenic cell line pairs are available to academic, non-profit and industry investigators via the "Fanconi Anemia Research Materials" Resource and Repository at Oregon Health & Sciences University, Portland OR.
Collapse
Affiliation(s)
- Hiep Tai Nguyen
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA
| | - Weiliang Tang
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA
| | - Andrew L H Webster
- Laboratory of Genome Maintenance, Rockefeller University, New York, New York, USA
| | - Jeffrey R Whiteaker
- Fred Hutchinson Cancer Center, Clinical Research Division, Seattle, Washington, USA
| | - Christopher M Chandler
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA
| | - Ricardo Errazquin
- Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain
- Biomedical Oncology Unit, CIEMAT (Centro de Investigaciones Energéticas, Medio-ambientales y Tecnológicas), Madrid, Spain
| | | | - Madeline Fritzke
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA
| | | | - Erica Jonlin
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA
- University of Washington Institute for Stem Cell and Regenerative Medicine, Seattle, Washington, USA
| | - Leslie Wakefield
- Departments of Pediatrics and Molecular and Medical Genetics, Oregon Health and Sciences University, Portland, Oregon, USA
| | - Lucas B Sullivan
- Fred Hutchinson Cancer Center, Human Biology Division, Seattle, Washington, USA
| | - Eleanor Y Chen
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA
| | | | - Ruud Brakenhoff
- Amsterdam University Medical Center, Amsterdam, The Netherlands
| | - Amanda G Paulovich
- Fred Hutchinson Cancer Center, Clinical Research Division, Seattle, Washington, USA
| | - Markus Grompe
- Departments of Pediatrics and Molecular and Medical Genetics, Oregon Health and Sciences University, Portland, Oregon, USA
| | - Ramon Garcia-Escudero
- Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain
- Biomedical Oncology Unit, CIEMAT (Centro de Investigaciones Energéticas, Medio-ambientales y Tecnológicas), Madrid, Spain
- Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
| | - Susanne I Wells
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
| | - Agata Smogorzewska
- Laboratory of Genome Maintenance, Rockefeller University, New York, New York, USA
| | - Raymond J Monnat
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA
- Department of Genome Sciences, University of Washington, Seattle, Washington, USA
| |
Collapse
|